3D Printed Drugs Market Analysis

Technology (Inkjet Printing, Zipdose Technology, Stereolithography)

The global 3D printed drugs market is segmented and analyzed for demand and supply by technology into inkjet printing, zipdose technology, and stereolithography. Among these segments, the zipdose technology segment is anticipated to capture the largest market size in the global 3D printed drugs market owing to the rise in the number of people suffering from dysphagia. It was observed that the prevalence of dysphagia in hospitalized patients ranges from 15% to 17%. Approximately 31% to 59% of nursing home residents suffer from dysphagia symptoms. In addition to being easy to use, this makes swallowing the drugs easier and proves to be effective for patients with dysphagia. Moreover, the growing demand for quickly dispersible drugs among geriatric and pediatric patients is expected to augment segment growth over the forecast period.

Our in-depth analysis of the global drugs market includes the following segments:

By Technology

Inkjet Printing
Zipdose Technology
Stereolithography

By Application

Orthopedic
Neurology

By End User

Hospitals
Clinics
Research Laboratories

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of 3D printed drugs is estimated at USD 245.1 million.

The 3D printed drugs market size was valued at USD 231.4 million in 2024 and is poised to cross USD 583.03 million by the end of 2037, expanding at more than 7.3% CAGR during the forecast period i.e., between 2025-2037. Rising geriatric population, growing prevalence of chronic diseases, along with advantages of 3D printed drugs over general drugs such as low cost and better solubility will boost the market growth.

North America industry is likely to hold majority revenue share by 2037, propelled by growing incidence of chronic diseases and increasing health awareness among people in the region.

The major players in the market include Extend Biosciences, Bioduro, Affinity Therapeutics, Osmotica Pharmaceuticals, Acrux, Thiomatrix, Ico Therapeutics Inc., Formac Pharmaceuticals, BiopharmX, Pacira Pharmaceuticals Inc.

3D Printed Drugs Market Analysis